All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| GWP / GW Pharmaceuticals plc
|
|
|
|
|
|
|
|
| PDSB / PDS Biotechnology Corporation
|
|
|
|
|
|
|
|
| BIIB / Biogen Inc. Call
|
|
|
|
|
|
|
|
| ARQL / ArQule, Inc.
|
|
|
|
|
|
|
|
| FTSV / Forty Seven, Inc.
|
|
|
|
|
|
|
|
| ETTX / Entasis Therapeutics Holdings Inc
|
|
|
|
|
|
|
|
| BOLD / Boundless Bio, Inc.
|
|
|
|
|
|
|
|
| 018490100 / Allergan plc Call
|
|
|
|
|
|
|
|
| AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CNAT / Conatus Pharmaceuticals Inc. Call
|
|
|
|
|
|
|
|
| APLS / Apellis Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| GLPG / Galapagos NV - Depositary Receipt (Common Stock) Put
|
|
|
|
|
|
|
|
| ONCE / Spark Therapeutics, Inc.
|
|
|
|
|
|
|
|
| DCPH / Deciphera Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| ITRM / Iterum Therapeutics plc
|
|
|
|
|
|
|
|
| MOR / MorphoSys AG - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
| OSMT / Osmotica Pharmaceuticals Plc
|
|
|
|
|
|
|
|
| TGTX / TG Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BHVN / Biohaven Ltd.
|
|
|
|
|
|
|
|
| ABBV / AbbVie Inc.
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| KDMN / Kadmon Holdings Inc
|
|
|
|
|
|
|
|
| CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
| OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
| PBYI / Puma Biotechnology, Inc. Call
|
|
|
|
|
|
|
|
| OEF / iShares Trust - iShares S&P 100 ETF Put
|
|
|
|
|
|
|
|
| ZGNX / Zogenix Inc Call
|
|
|
|
|
|
|
|
| FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
| XBIT / XBiotech Inc.
|
|
|
|
|
|
|
|
| ACRS / Aclaris Therapeutics, Inc.
|
|
|
|
|
|
|
|
| FOMX / Foamix Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
| ACOR / Acorda Therapeutics, Inc.
|
|
|
|
|
|
|
|
| HALO / Halozyme Therapeutics, Inc.
|
|
|
|
|
|
|
|
| APLT / Applied Therapeutics, Inc.
|
|
|
|
|
|
|
|
| US74257L1089 / Principia Biopharma Inc.
|
|
|
|
|
|
|
|
| 018490100 / Allergan plc
|
|
|
|
|
|
|
|
| AMGN / Amgen Inc. Put
|
|
|
|
|
|
|
|
| US16706W1027 / Chiasma Inc
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| 14161H108 / Cardtronics PLC
|
|
|
|
|
|
|
|
| DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
| ANAB / AnaptysBio, Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
| QURE / uniQure N.V. Call
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
| BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
| BMYMP / Bristol-Myers Squibb Company - Preferred Security Call
|
|
|
|
|
|
|
|
| AKBA / Akebia Therapeutics, Inc.
|
|
|
|
|
|
|
|
| 0PP / Portola Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CALA / Calithera Biosciences, Inc.
|
|
|
|
|
|
|
|
| IMGN / ImmunoGen, Inc. Call
|
|
|
|
|
|
|
|
| ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
| ITCI / Intra-Cellular Therapies, Inc. Call
|
|
|
|
|
|
|
|
| DCPH / Deciphera Pharmaceuticals, Inc. Put
|
|
|
|
|
|
|
|
| ZYME / Zymeworks Inc.
|
|
|
|
|
|
|
|
| ICPT / Intercept Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
| MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
| KALA / KALA BIO, Inc.
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
| OBSV / ObsEva SA.
|
|
|
|
|
|
|
|
| BPMC / Blueprint Medicines Corporation
|
|
|
|
|
|
|
|
| NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| NXTC / NextCure, Inc.
|
|
|
|
|
|
|
|
| KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| FGEN / FibroGen, Inc.
|
|
|
|
|
|
|
|
| ALNY / Alnylam Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| KNSA / Kiniksa Pharmaceuticals, Ltd.
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| SVRA / Savara Inc.
|
|
|
|
|
|
|
|
| MRUS / Merus N.V.
|
|
|
|
|
|
|
|
| YMAB / Y-mAbs Therapeutics, Inc.
|
|
|
|
|
|
|
|
| RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
|
|
|
|
|
| ABBV / AbbVie Inc. Call
|
|
|
|
|
|
|
|
| VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
| SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| INCY / Incyte Corporation
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NCNA / NuCana plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| SYBX / Synlogic, Inc.
|
|
|
|
|
|
|
|
| FGEN / FibroGen, Inc. Put
|
|
|
|
|
|
|
|
